Proteomics may reveal hidden clues to rare disease treatment success
Knowledge-focused
ENROLLING_BY_INVITATION
This study aims to identify proteins in blood, saliva, and sputum that can help doctors predict organ damage and how well patients with EGPA (a rare inflammatory disease) or severe asthma respond to the drug mepolizumab. Researchers will analyze samples from 90 participants befor…
Phase: PHASE4 • Sponsor: Azienda Ospedaliero Universitaria di Cagliari • Aim: Knowledge-focused
Last updated May 26, 2026 11:59 UTC